Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India

References

• Mettananda S, Gibbons RJ, Higgs DR. α-Globin as a molecular target in the treatment of β-thalassemia. Blood. 2015;125(24):3694–3701.
   PubMed Web of Science ®Google Scholar
• Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364(9442):1343–1360.
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. The definition and epidemiology of non-transfusion-dependent thalassemia. Blood Rev. 2012;26(Suppl 1):S3–S6.
   PubMed Web of Science ®Google Scholar
• Durand PM, Coetzer TL. Hereditary red cell disorders and malaria resistance. Haematologica. 2008;93(7):961–963.
   PubMed Web of Science ®Google Scholar
• Hedrick PW. Population genetics of malaria resistance in humans. Heredity. 2011;107(4):283–304.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet. 2005;77(2):171–192.
   PubMed Web of Science ®Google Scholar
• Allison AC. Protection afforded by sickle-cell trait against subtertian malareal infection. BMJ. 1954;1(4857):290–294.
   PubMed Web of Science ®Google Scholar
• Balgir RS. The burden of haemoglobinopathies in India and the challenges ahead. Curr Sci. 2000;79(11):1536–1547.
   Web of Science ®Google Scholar
• Omoti CE. β Thalassaemia traits in Nigerian patients with sickle cell anaemia. J Med Biomed Res. 2005;4(1):37–43.
   Google Scholar
• Choubey M, Mishra H, Soni K, et al. Implementation of indigenous electronic medical record system to facilitate care of sickle cell disease patients in Chhattisgarh. J Clin Diagn Res. 2016;10(2):LC01–LC06.
   PubMed Web of Science ®Google Scholar
• Serjeant GR, Serjeant BE. Sickle cell-β thalassemia. In: Serjeant GR, Ed. Sickle Cell Disease, 3 ed. Oxford (Oxfordshire): Oxford University Press. 2001:281–300.
   Google Scholar
• Steinberg MH. Compound heterozygous and other sickle hemoglobinopathies. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management. Cambridge (Cambridgeshire, UK): Cambridge University Press. 2001:786–810.
   Google Scholar
• Domingos IF, Falcao DA, Hatzlhofer BL, et al. Influence of the βS haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cell anaemia. Ann Hematol. 2014;93(7):1123–1129.
   PubMed Web of Science ®Google Scholar
• Filho IL, Leite AC, Moura PG, et al. Genetic polymorphisms and cerebrovascular disease in children with sickle cell anemia from Rio de Janeiro, Brazil. Arq Neuropsiquiatr. 2011;69(3):431–435.
   PubMed Web of Science ®Google Scholar
• Nebor D, Broquere C, Brudey K, et al. α-Thalassemia is associated with a decreased occurrence and a delayed age-at-onset of albuminuria in sickle cell anemia patients. Blood Cells Mol Dis. 2010;45(2):154–158.
   PubMed Web of Science ®Google Scholar
• Adorno EV, Zanette A, Lyra I, et al. The β-globin gene cluster haplotypes in sickle cell anemia patients from Northeast Brazil: a clinical and molecular view. Hemoglobin. 2004;28(3):267–271.
   PubMed Web of Science ®Google Scholar
• Guasch A, Zayas CF, Eckman JR, et al. Evidence that microdeletions in the α globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol. 1999;10(5):1014–1019.
   PubMed Web of Science ®Google Scholar
• Steinberg MH, Hsu H, Nagel RL, et al. Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am J Hematol. 1995;48(3):175–181.
   PubMed Web of Science ®Google Scholar
• Silvestroni E, Bianco I. Microdrepanocito-anemia in un soggetto di razza Bianca. Boll A Accad Med Roma. 1944;70:347–354.
   Google Scholar
• Verma IC, Saxena R, Kohli S. Hemoglobinopathies in India – Clinical and laboratory aspects. Clin Lab Med. 2012;32(2):249–262.
   PubMed Web of Science ®Google Scholar
• Mukherjee MB, Nadkarni AH, Gorakshakar AC, et al. Clinical, hematologic and molecular variability of sickle cell-β thalassemia in western India. Indian J Hum Genet. 2010;16(3):154–158.
   PubMedGoogle Scholar
• Figueiredo MS. The compound state: Hb S/β-thalassemia. Rev Bras Hematol Hemoter. 2015;37(3):150–152.
   PubMedGoogle Scholar
• Serjeant GR, Serjeant BE, Fraser RA, et al. Hb S-β-thalassemia: molecular, hematological and clinical comparisons. Hemoglobin. 2011;35(1):1–12.
   PubMed Web of Science ®Google Scholar
• Patra PK, Khodiar PK, Hambleton IR, et al. The Chhattisgarh State screening programme for the sickle cell gene: a cost-effective approach to a public health problem. J Commun Genet. 2015;6(4):361–368.
   PubMed Web of Science ®Google Scholar
• Gupta A, Hattori Y, Gupta UR, et al. Molecular genetic testing of β-thalassemia patients of Indian origin and a novel 8-bp deletion mutation at codons 36/37/38/39. Genet Test. 2003;7(2):163–168.
   PubMedGoogle Scholar
• Agarwal S, Pradhan M, Gupta UR, et al. Geographic and ethnic distribution of β-thalassemia mutations in Uttar Pradesh, India. Hemoglobin. 2000;24(2):89–97.
   PubMed Web of Science ®Google Scholar
• Vaz FE, Thakur CB, Banerjee MK, et al. Distribution of β-thalassemia mutations in the Indian population referred to a diagnostic center. Hemoglobin. 2000;24(3):181–194.
   PubMed Web of Science ®Google Scholar
• Moorjani P, Thangaraj K, Patterson N, et al. Genetic evidence for recent population mixture in India. Am J Hum Genet. 2013;93(3):422–438.
   PubMed Web of Science ®Google Scholar
• Reich D, Thangaraj K, Patterson N, et al. Reconstructing Indian population history. Nature. 2009;461(7263):489–494.
   PubMed Web of Science ®Google Scholar
• Dhandapany PS, Sadayappan S, Xue Y, et al. A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat Genet. 2009;41(2):187–191.
   PubMed Web of Science ®Google Scholar
• Jha AN, Sundaravadivel P, Singh VK, et al. MBL2 Variations and Malaria Susceptibility in Indian Populations. Infection and immunity. 2014 Jan;82(1):52–61.
   PubMed Web of Science ®Google Scholar
• Jha AN, Singh VK, Kumari N, et al. IL-4 haplotype -590T, -34T and intron-3 VNTR R2 is associated with reduced malaria risk among ancestral indian tribal populations. PloS One. 2012;7(10):e48136.
   PubMed Web of Science ®Google Scholar
• Kulkarni GD, Kulkarni SS, Kadakol GS, et al. Molecular basis of β-thalassemia in Karnataka, India. Genet Test Mol Biomarkers. 2012;16(2):138–141.
   PubMed Web of Science ®Google Scholar
• Patel AG, Shah AP, Sorathiya SM, et al. Hemoglobinopathies in South Gujarat population and incidence of anemia in them. Indian J Hum Genet. 2012;18(3):294–298.
   PubMedGoogle Scholar
• Balgir RS. The spectrum of haemoglobin variants in two scheduled tribes of Sundargarh district in north-western Orissa, India. Ann Hum Biol. 2005;32(5):560–573.
   PubMed Web of Science ®Google Scholar
• Feroze M, Aravindan KP. Sickle cell disease in Wayanad, Kerala: gene frequencies and disease characteristics. Natl Med J India. 2001;14(5):267–270.
   PubMed Web of Science ®Google Scholar
• Patel AP, Parmar PH, Patel RB, et al. Factors influencing β-thalassemia awareness in Western India. Natl J Community Med. 2016;7(3):193–197.
   Google Scholar
• Kaur M, Dangi CBS, Singh M, et al. Burden of sickle cell disease among tribes of India: a burning problem. Int Res J Pharm App Sci. 2013;3(1):60–80.
   Google Scholar
• Colah R, Mukherjee M, Ghosh K. Sickle cell disease in India. Curr Opin Hematol. 2014;21(3):215–223.
   PubMed Web of Science ®Google Scholar
• Jain D, Warthe V, Dayama P, et al. Sickle cell disease in Central India: a potentially severe syndrome. Indian J Pediatr. 2016;83(10):1071–1076.
   PubMed Web of Science ®Google Scholar
• Thein SL. The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. Blood Rev. 2012;26(Suppl 1):S35–S39.
   PubMed Web of Science ®Google Scholar
• Alsultan A, Alabdulaali MK, Griffin PJ, et al. Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign. Br J Haematol. 2014;164(4):597–604.
   PubMed Web of Science ®Google Scholar
• Cheetham RC, Huehns ER, Rosemeyer MA. Participation of Haemoglobins A, F, A2 and C in polymerisation of Haemoglobin S. J Mol Biol. 1979;129(1):45–61.
   PubMed Web of Science ®Google Scholar
• Inati A, Taher A, Bou Alawi W, et al. β-Globin gene cluster haplotypes and Hb F levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol. 2003;70(2):79–83.
   PubMed Web of Science ®Google Scholar
• Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–1644.
   PubMed Web of Science ®Google Scholar
• Powars DR, Weiss JN, Chan LS, et al. Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood. 1984;63(4):921–926.
   PubMed Web of Science ®Google Scholar
• Alsultan A, Aleem A, Ghabbour H, et al. Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi Arabia. J Pediatr Hematol/Oncol. 2012;34(2):79–84.
   PubMed Web of Science ®Google Scholar